HCPCS Level II J9176: Injection, elotuzumab, 1 mg
HCPCS Level II code J9176 describes the drug supply for an injection of elotuzumab, billed per 1 mg; the service represents administration of a monoclonal antibody oncology medication and is typically reported when the drug is provided for infusion or injection in an outpatient infusion center or hospital outpatient department setting.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J9176 policy alerts
Get alerted when payer policies referencing J9176 are released or updated.
Monitor payer policy activity